Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
11 November 2021Website:
http://www.heartbeam.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 02 Jul 2024 23:35:28 GMTDividend
Analysts recommendations
Institutional Ownership
BEAT Latest News
- Data continue to support revumenib's potential to enhance current standard of care agents - - 96% CRc (23 of 24 pts) observed in BEAT AML trial exploring revumenib in combination with venetoclax/azacitidine in newly diagnosed mNPM1 or KMT2Ar AML - - 52% CRc (14 of 27 pts) observed in AUGMENT-102 trial of revumenib in combination with fludarabine-cytarabine in acute leukemia patients with R/R mNPM1, NUP98r or KMT2Ar - WALTHAM, Mass. , June 14, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced updated data from multiple combination trials of revumenib, the Company's potent, selective, small molecule menin inhibitor, in patients with acute leukemias.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias.
HeartBeam, Inc. (NASDAQ: BEAT) Q1 2024 Earnings Conference Call on May 9, 2024 at 4:30 PM ET with Company Participants Branislav Vajdic, Rob Eno, Rick Brounstein, and Brooks Hamilton, as well as Conference Call Participants Leo Carpio. Thank you for joining us for the HeartBeam First Quarter 2024 Financial Results Conference Call.
HeartBeam showcases successful outcomes in utilizing its artificial intelligence technology to identify irregular heart rhythms.
HeartBeam (NASDAQ: BEAT ) just reported results for the fourth quarter of 2023. HeartBeam reported earnings per share of -13 cents.
HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time.
HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Branislav Vajdic - Founder & Chief Executive Officer Robert Eno - President Richard Brounstein - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Operator Greetings and welcome to the HeartBeam Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
HeartBeam, Inc. (NASDAQ:BEAT ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Branislav Vajdic - Founder and Chief Executive Officer Rob Eno - President Richard Brounstein - Chief Financial Officer Conference Call Participants Jason Kolbert - Dawson James William Sutherland - The Benchmark Company Ben Haynor - Alliance Global Partners Operator Greetings and welcome to the HeartBeam First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen only mode.
What type of business is HeartBeam?
BioTelemetry, Inc. is a leading medical technology company specializing in providing remote services in various areas of healthcare. The key focus is on remote monitoring of various vital signs of outpatient patients. The company was founded in 1994, with headquarters located in Malvern, Pennsylvania. BioTelemetry, Inc. provides remote cardiac monitoring, centralized laboratory services for clinical trials, remote blood glucose monitoring, and the manufacturing of original equipment that serves clients in the healthcare system and clinical research. The company operates in two reporting segments: Healthcare Segment and Research Segment.
What sector is HeartBeam in?
HeartBeam is in the Healthcare sector
What industry is HeartBeam in?
HeartBeam is in the Health Information Services industry
What country is HeartBeam from?
HeartBeam is headquartered in United States
When did HeartBeam go public?
HeartBeam initial public offering (IPO) was on 11 November 2021
What is HeartBeam website?
https://www.heartbeam.com
Is HeartBeam in the S&P 500?
No, HeartBeam is not included in the S&P 500 index
Is HeartBeam in the NASDAQ 100?
No, HeartBeam is not included in the NASDAQ 100 index
Is HeartBeam in the Dow Jones?
No, HeartBeam is not included in the Dow Jones index
When does HeartBeam report earnings?
The next expected earnings date for HeartBeam is 09 August 2024